MX2023008351A - Heterodimeros de proteinas de membrana tipo i y metodos de uso de los mismos. - Google Patents
Heterodimeros de proteinas de membrana tipo i y metodos de uso de los mismos.Info
- Publication number
- MX2023008351A MX2023008351A MX2023008351A MX2023008351A MX2023008351A MX 2023008351 A MX2023008351 A MX 2023008351A MX 2023008351 A MX2023008351 A MX 2023008351A MX 2023008351 A MX2023008351 A MX 2023008351A MX 2023008351 A MX2023008351 A MX 2023008351A
- Authority
- MX
- Mexico
- Prior art keywords
- type
- heterodimers
- methods
- heterodimer
- membrane proteins
- Prior art date
Links
- 108010052285 Membrane Proteins Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000833 heterodimer Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102100026882 Alpha-synuclein Human genes 0.000 abstract 1
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 abstract 1
- 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 abstract 1
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 abstract 1
- 101000836954 Homo sapiens Sialic acid-binding Ig-like lectin 10 Proteins 0.000 abstract 1
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 abstract 1
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 abstract 1
- 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 101150036449 SIRPA gene Proteins 0.000 abstract 1
- 102100027164 Sialic acid-binding Ig-like lectin 10 Human genes 0.000 abstract 1
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163136687P | 2021-01-13 | 2021-01-13 | |
| US202163139331P | 2021-01-20 | 2021-01-20 | |
| PCT/IL2022/050055 WO2022153307A1 (en) | 2021-01-13 | 2022-01-13 | Type i membrane proteins heterodimers and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023008351A true MX2023008351A (es) | 2023-10-10 |
Family
ID=82447997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023008351A MX2023008351A (es) | 2021-01-13 | 2022-01-13 | Heterodimeros de proteinas de membrana tipo i y metodos de uso de los mismos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240076346A1 (enExample) |
| EP (1) | EP4277923A4 (enExample) |
| JP (1) | JP2024503685A (enExample) |
| KR (1) | KR20230169933A (enExample) |
| AU (1) | AU2022208466A1 (enExample) |
| BR (1) | BR112023013898A2 (enExample) |
| CA (1) | CA3204707A1 (enExample) |
| IL (1) | IL304381A (enExample) |
| MX (1) | MX2023008351A (enExample) |
| WO (1) | WO2022153307A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2769769C2 (ru) | 2017-01-05 | 2022-04-05 | Кахр Медикал Лтд. | СЛИТЫЙ БЕЛОК SIRPα-4-1BBL И СПОСОБЫ ЕГО ПРИМЕНЕНИЯ |
| CN110536693B (zh) | 2017-01-05 | 2023-12-22 | 卡尔医学有限公司 | Pd1-41bbl融合蛋白及使用其的方法 |
| US11566060B2 (en) | 2017-01-05 | 2023-01-31 | Kahr Medical Ltd. | PD1-CD70 fusion protein and methods of use thereof |
| EP3820887A4 (en) | 2018-07-11 | 2022-04-20 | KAHR Medical Ltd. | Pd1-4-1bbl variant fusion protein and methods of use thereof |
| KR102945860B1 (ko) | 2018-07-11 | 2026-03-31 | 카 메디컬 리미티드 | SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법 |
| CN111454369A (zh) * | 2020-04-10 | 2020-07-28 | 润方(长春)生物科技有限公司 | 一种用于制备异二聚物蛋白质的方法 |
| US20250051410A1 (en) * | 2021-12-23 | 2025-02-13 | Kahr Medical Ltd. | Lilrb polypeptides and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| WO2014164519A1 (en) * | 2013-03-12 | 2014-10-09 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for inhibiting the effects of amyloid beta oligomers |
| WO2016023001A1 (en) * | 2014-08-08 | 2016-02-11 | The Board Of Trustees Of The Leland Stanford Junior University | Multispecific high affinity pd-1 agents and methods of use |
| CN113831417B (zh) * | 2017-05-08 | 2024-10-01 | 上海津曼特生物科技有限公司 | 双特异性重组蛋白及其应用 |
| CN107857819A (zh) * | 2017-07-03 | 2018-03-30 | 江苏西迪尔生物技术有限公司 | 多功能融合蛋白及其应用 |
| EP3908664A4 (en) * | 2019-01-07 | 2023-01-25 | Thomas Jefferson University | MULTIFUNCTIONAL FUSION PROTEINS AND THEIR USES |
| EP3947460A4 (en) * | 2019-03-26 | 2023-05-10 | Forty Seven, Inc. | MULTISPECIFIC AGENTS FOR TREATMENT OF CANCER |
| TWI760751B (zh) * | 2019-05-29 | 2022-04-11 | 美商美國禮來大藥廠 | Tigit及pd-1/tigit-結合分子 |
| CN110128550B (zh) * | 2019-05-30 | 2023-01-13 | 南京惟亚德生物医药有限公司 | 一种新型的同时阻断免疫检查点pd-l1和tigit的复制型溶瘤腺病毒和应用 |
| US20220267409A1 (en) * | 2019-07-11 | 2022-08-25 | Kahr Medical Ltd. | Heterodimers and methods of use thereof |
-
2021
- 2021-01-13 US US18/272,154 patent/US20240076346A1/en active Pending
-
2022
- 2022-01-13 AU AU2022208466A patent/AU2022208466A1/en active Pending
- 2022-01-13 KR KR1020237027209A patent/KR20230169933A/ko active Pending
- 2022-01-13 WO PCT/IL2022/050055 patent/WO2022153307A1/en not_active Ceased
- 2022-01-13 EP EP22739265.1A patent/EP4277923A4/en active Pending
- 2022-01-13 MX MX2023008351A patent/MX2023008351A/es unknown
- 2022-01-13 BR BR112023013898A patent/BR112023013898A2/pt unknown
- 2022-01-13 CA CA3204707A patent/CA3204707A1/en active Pending
- 2022-01-13 JP JP2023542757A patent/JP2024503685A/ja active Pending
-
2023
- 2023-07-10 IL IL304381A patent/IL304381A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL304381A (en) | 2023-09-01 |
| KR20230169933A (ko) | 2023-12-18 |
| WO2022153307A1 (en) | 2022-07-21 |
| AU2022208466A1 (en) | 2023-08-17 |
| JP2024503685A (ja) | 2024-01-26 |
| BR112023013898A2 (pt) | 2023-10-31 |
| AU2022208466A9 (en) | 2024-07-11 |
| CA3204707A1 (en) | 2022-07-21 |
| EP4277923A1 (en) | 2023-11-22 |
| US20240076346A1 (en) | 2024-03-07 |
| EP4277923A4 (en) | 2025-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023008351A (es) | Heterodimeros de proteinas de membrana tipo i y metodos de uso de los mismos. | |
| MX2022000367A (es) | Heterodimeros, metodos y uso de los mismos. | |
| MX2021000263A (es) | Proteina de fusion variante sirpalfa-4-1bbl y procedimientos de uso de la misma. | |
| WO2021198706A3 (en) | Coronavirus vaccines | |
| NZ778392A (en) | Polypeptides useful for gene editing and methods of use | |
| EA202192501A1 (ru) | Рекомбинантные аденоассоциированные вирусные векторы | |
| MX2022006018A (es) | Nanoporos artificiales y usos y metodos relacionados con los mismos. | |
| EP3833386A4 (en) | MULTISPECIFIC BINDING PROTEINS FOR BINDING HER2, NKG2D AND CD16 AND METHODS OF USE | |
| WO2022024024A3 (en) | Proteins comprising hla-g antigen binding domains and their uses | |
| DK0539530T3 (da) | Rensningsstyret kloning af peptider | |
| BR112018000660A2 (pt) | peptídeos anti-inflamatórios e seu uso | |
| CY1110670T1 (el) | Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων | |
| ATE496134T1 (de) | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden | |
| DE69133281D1 (de) | Rezeptoren der wachstumsfaktoren aus fibroblasten | |
| EP4566622A3 (en) | Dap10/dap12 fusion polypeptides | |
| WO2021252975A3 (en) | Split intein-based selection for peptide binders | |
| DE60111259D1 (de) | Membranfusion-proteine von reovirus | |
| BR112023019385A2 (pt) | Composições compreendendo polipeptídeos de fusão nkg2d, cxcr2 e dap10/dap12 e seus métodos de uso | |
| EP1702071A4 (en) | TRANSACTIVATION SYSTEM FOR MAMMALIAN CELLS | |
| ATE377649T1 (de) | Verfahren und zelle zur expression von rekombinanten proteinprodukten | |
| BR112017022076A2 (pt) | fusões de mesotelina-variante iii de receptor de fator de crescimento epidérmico e métodos de uso das mesmas | |
| AR009647A1 (es) | Un polinucleotido de hebras simples o dobles aislado, un vector que lo comprende, uso de un vector para transformar una celula huesped, un polipeptidoaislado y purificado y un procedimiento recombinante para la expresion de un polipeptido que es codificado por dicho polinucleotido. | |
| MX2025005382A (es) | Fago sintético con proteínas de espicula de cola de fago recombinantes y métodos relacionados | |
| NO922421L (no) | Collagenbindende protein, samt fremstilling derav | |
| MX2025006628A (es) | Receptores olfativos modificados |